Download theTranscript »
Panelists will discuss new medical applications for common drugs of abuse. “Club Drugs” including nitrous oxide, ketamine, and MDMA are seeing increasing use by medical doctors as treatments for conditions like depression and PTSD, despite their not being approved for such use by the FDA. The panelists will talk about the abuse of these drugs and their research into new, legitimate uses.
Ketamine, widely used legally as an anesthetic and illegally in club settings is emerging as a potential new treatment for some types of depression. Dr. Gerard Sanacora—Professor of Psychiatry, Yale School of Medicine—will share his research on Ketamine and its uses in treating depression.
Dental patients are familiar with Nitrous Oxide, popularly known as “laughing gas.” Dr. Charles Conway—Professor of Psychiatry at Washington University School of Medicine in St. Louis—will discuss his research on Nitrous Oxide and the potential for it and other drugs of abuse to be used as treatments for depression.
Dr. Jean Lud Cadet—Chief of the Molecular Neuropsychiatry Research Branch and Associate Director for Diversity and Outreach at the Intramural Research Program (IRP) of NIDA—will discuss the potential use and abuse of MDMA, Methamphetamine, and other drugs for PTSD and other psychiatric diatheses.
This event is free and open to the public.
- Mark S. Gold, MD (Moderator)
Chairman of Rivermend Health’s Scientific Advisory Boards
- Gerard Sanacora, PhD, MD
Professor of Psychiatry, Yale School of Medicine; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service
Topic: “Ketamine for Depression”
- Charles Conway, MD
Professor of Psychiatry, Washington University School of Medicine in St. Louis
Topic: “Laughing Gas and Other Drugs of Abuse Used As Treatments for Depression”
- Jean Lud Cadet, MD
Chief of the Molecular Neuropsychiatry Research Branch and Associate Director for Diversity and Outreach at the Intramural Research Program (IRP) of NIDA
Topic: “Potential use and abuse of MDMA, Methamphetamine, and other drugs for PTSD and other psychiatric diatheses”
A New Look at Old and Not So Old Drugs: A 2018 Update on Cocaine
Moderated by Mark Gold, M.D.
With Cocaine on the comeback trail, please join us as four researchers provide updates on this re-emerging issue.
- Mark S. Gold, MD, Chairman of Rivermend Health’s Scientific Advisory Boards, Moderator, and CDC and Coroners Death Records for Cocaine
- Leah Bloomenstein, DEA (Domestic Intel), Current Intelligence on Cocaine
- Jean Lud Cadet, MD, National Institute on Drug Abuse (NIDA), Cocaine Changes the Brain and Damages It
- Tom Kosten, MD, Baylor College of Medicine, Treatment for Cocaine OD or Addictions?
Download the Transcript | PPT presentation
October 5, 1:00 PM Eastern Time, DEA Auditorium
A New Look at Old and Not So Old Drugs: A 2017 Update on Marijuana Research
Moderated by Robert DuPont, M.D.
With Marijuana in the news–both with state-level legalization efforts and research on its effects on the body and brain, please join us as four renowned international researchers provide updates on these issues.
- Bertha Madras, Ph.D. Professor Harvard Medical School & former Deputy Director for Demand Reduction, ONDCP
“Marijuana’s risks for the adolescent brain and development”
- Arpana Agrawal, Ph.D., Psychiatric Genetics Consortium & Associate Professor, Washington University School of Medicine, St Louis
“Marijuana exposure in young people increases risks of schizophrenia, depression & anhedonia”
- Adriaan Bruijnzeel, Ph.D., Associate Professor UFBI
“Original brain studies prove second hand Marijuana, like tobacco smoke, is addicting”
- Robert DuPont, M.D., Founding Director, NIDA and former Drug Czar
“Second hand effects of Marijuana smoke in life”
Download the transcript »
April 27, 11:00 AM Eastern
Retired DEA Special Agent in Charge Jeffrey B. Stamm, Executive Director, Midwest High Intensity Drug Trafficking Area (HIDTA)
Jeff Stamm is a 31-year veteran of DEA who retired after serving as the Special Agent in Charge of the Aviation Division, and is an amateur historian of America’s drug enforcement experiences beginning with the Harrison Narcotics Act of 1914. Mr. Stamm will provide his perspectives of our nation’s current global efforts to control the use and trafficking of illegal drugs, as well as countering some of the myths that have been put forth. With abundant examples drawn from his experiences on the job, his scholarship, and from the history of DEA—which he refers to as “the indispensable agency”—Mr. Stamm will speak on America’s current drug control policy that, to paraphrase Churchill, is the worst system ever devised by the wit of man – except for all the others!
Download Lecture Transcript »
Tuesday, March 22, 11:00 AM Eastern
The Heroin Epidemic: Then and Now – Lessons Learned
Please join former DEA Administrator Peter Bensinger and former NIDA Director Robert DuPont, MD, who will outline the steps taken during the late 1970s to reduce the supply of heroin in the United States to increase the price and reduce the purity, with direct impact on the number of heroin users and overdose deaths. Former Administrator Bensinger will discuss at least two major heroin initiatives, Operation Heroin B and Operation Trizo. Dr. DuPont will highlight the crucial role of DEA, and law enforcement generally, in a public health approach to the heroin epidemic and lessons learned from the 1970s heroin epidemic.
Download Peter Bensinger Lecture Slides »
Download Robert DuPont, MD Lecture Slides »
Download Lecture Transcript »
Tuesday, November 17, 11:00 AM Eastern
Opiate Misuse, Overdose, & Addiction – Causes & Solutions
Opiate addiction along with pain management combined with substance use disorders is a growing concern. Please join us as we learn from two very distinguished scientists about opiates. Dr. Theodore J. Cicero, Professor of Psychiatry at Washington University in St. Louis will speak on The Opiate Overdose & Addiction Epidemic. Dr. William S. Jacobs, Chief of Addiction Medicine at the Medical College of Georgia & Medical Director of the Bluff Plantation, will speak on The Role of Pain, Pain Medicine, and Physicians in Treatment of Pain and Substance Use Disorders (SUDs).
The presentation will be moderated by Dr. Mark Gold, best known for his work on the brain systems underlying the effects of drugs; distinguished alumnus of Washington University, University of Florida, and Yale University; Chairman of the Scientific Advisory Boards for RiverMend Health; and Director of Research and Prevention for the DEA Educational Foundation. Download the lecture slides » | Download the transcript »
Thursday, October 22, 11:00 AM Eastern
The DEA Forensics Labs – Then and Now
DEA’s ability to arrest and prosecute drug traffickers relies on a team, and one important part of this team is DEA’s Forensic Science Laboratories around the country. Please join us via live webcast as we visit DEA’s Special Testing Laboratory and find out how DEA forensic science has evolved from its beginnings many years ago, to the current cutting-edge science and technology it uses today. Read the transcript »
Thursday, June 25, 2015, 11:00 AM Eastern
Operation Tiger Trap: The Rise and Fall of Khun Sa & The Drug Trade in SE Asia
Please join retired DEA Country Attaché John Whalen as he discusses narcotics trafficker Khun Sa and DEA’s Operation Tiger Trap. His presentation will cover Khun Sa’s rise to power, his eventual fall, how Operation Tiger Trap facilitated his demise, and how the vacuum created by his surrender to the Burmese government has been filled by other non-state armed groups in Burma who continue to traffic in narcotics. Please join us at the DEA Museum auditorium or via free live webcast.
Download the flyer »
Wednesday, April 22, 2015, 11 AM Eastern
A Look Behind the Curtain: The History of DEA’s Special Operations Division
Operations Adam Bomb, Crystal Light, One-Eyed Mule & Angry Pirate – these are just a few of the many drug interdictions overseen by DEA’s Special Operations Division (SOD). Please join us for a spirited discussion on the history of this division as we take a look behind the curtain. This program will feature panelists Michael Horn, former DEA Chief of International Operations; Joseph Keefe, former DEA Chief of Operations; Robert Nieves, former DEA Chief of International Operations; and John Wallace, former DEA Chief Counsel for International Law & Intelligence. It will be moderated by DEA Acting Chief of Congressional and Public Affairs Gary Owen. Please join us at the DEA Museum Auditorium or via free live webcast.
Download transcript »
Thursday, November 6, 2014, 11 AM Eastern
Targeting the Mafia: FBN, Organized Crime, and Drugs
In the first half of the 20th century, the Mafia as a criminal organization was not yet into drugs. In the post-World War II era, Mafia members in New York City, the hub of the heroin trade in the U.S., became active in the heroin trade, eventually hooking up with European drug sources from the infamous “Unione Corse” and “French Connection.” Narcotic Agents of the Federal Bureau of Narcotics (FBN) kept close tabs on them and regularly compiled intelligence reports that helped produce numerous arrests and convictions. In later years, this extensive knowledge base of these old Mafia family ties and associations would prove invaluable. Join former FBN Narcotic Agent and retired DEA Assistant Administrator for Operations John J. Coleman, PhD, as he discusses FBN, organized crime, and drugs in the 1960s.
Download transcript »